Fat Stem Cell Extraction one of the 50 Best Inventions of the Year – Time Magazine
Amyotrophic lateral sclerosis is one of the most distressing neurodegenerative disorders, which is typified by gradual deterioration of motor neurons. This happens in the spinal cord, cortex, and the brainstem. As a result of this disorder, patients suffer from respiratory deficiency as well as paralysis, which ultimately prove fatal. Comprehending the causes of ALS makes the treatment of this disorder even more difficult. However, stem cell treatment has surfaced as a promising treatment of late. With ongoing research and development around the world ALS treatment India is also growing at a fast pace. India n hospitals and centers are also involved vigorously in research and development activities to make Stem Cell therapy more accessible.
There is huge potential of Stem Cell therapy in treating cardiovascular, neurological, as well as ocular disorders. Several clinical studies regarding ALS treatment India are being carried out with stress on autologous stem cells, progenitor and stem cells, and at the same time, researchers are also trying to maintain highest standards and ethical values to match the global standards.
In the recent times cases of Amyotrophic lateral sclerosis is on the rise, and many other diseases related to lifestyle is also increasing rapidly with rapid increase in the population. Along with ALS treatment India, many other therapies will be launched in the India n market in the next few years. Given that, stem cells comprise of the power to differentiate into a variety of cells, these put forward treatment options for a number of degenerative diseases and disorders. Other than treatment of Amyotrophic lateral sclerosis, Stem Cell therapy is also used in treating other motor neuron ailments such as spinal muscular atrophy, primary lateral sclerosis, progressive bulbar palsy, and progressive muscular atrophy. Motor neuron disorders like ALS reduce quality and span of life drastically, and stem cell transplantation has emerged as an ideal treatment.
6th Annual World Congress of Molecular & Cell Biology
Time: 25-28 April, 2016 Place: Dalian, China
Dear Anand S Srivastava,
Hope you everything goes well.
This is Judy from the organizing committee of CMCB-2016. I have sent you an invitation letter concerning the oral presentation at this congress but unfortunately without hearing from you.
We are honored to announce that the 6th Annual World Congress of Molecular & Cell Biology (CMCB-2016) will be hold during April 25-28, 2016 in Dalian, China, with the theme “Unlocking the Secrets of Cells”. On behalf of the organizing committee, I am writing to you to propose a Speech on your recent research about Mesenchymal Stem Cells in Regenerative Medicine… for the Forum 6-2: Tissue Repair & Regeneration. We believe that your participation will add great value for CMCB-2016. For more information, please visit the conference website at http://www.bitcongress.com/cmcb2016/.
CMCB successfully began with 2011, there were more than 200 participants from over 26 countries and areas have attended the CMCB-2011. Participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysis the development of Molecular & Cell Biology. The CMCB-2012, CMCB-2013 and CMCB-2014 had also been successfully held in Beijing, Suzhou and Dalian. CMCB-2015 was just held simultaneously with other 7 conferences in Nanjing. It was a grand meeting with thousands of people for science and technology, which absolutely brought us a big breakthrough. Depending on the warmly support and valuable suggestions from all of the participants, we are confident in organizing CMCB-2016.
Since cell and molecular biology have made tremendous strides over time, we aim to bring together biochemists, molecular biologists, cell and developmental biologists and other professionals, who are active in the field of molecular and cell biology, to present their exciting new findings in major plenary forum and in a wide array of more special sessions.
A rich selection of topics will be addressed during CMCB-2016, which includes:
Forum 1: Forefront in Cellular Structures, Functions and Events
Forum 2: Hot Stories of Stem Cells
Forum 3: New Ideas in Cell Energy and Metabolism
Forum 4: Cutting Edge Topics in RNA Biology
Forum 5: State-of-the-Art Technologies for Cell
Forum 6: Translational Molecular & Cell Biology
The program of CMCB is promised to be informative; it will foster the collaborations among professionals in China and beyond.
Dalian – China’s Best Tourist City. With beautiful scenery, a nice climate and fast development, this romantic city ranks among China’s best tourist destinations in many people’s minds. It is also a trading and financial center in northeastern Asia and has gained the name “Hong Kong of Northern China”. We hope you will enjoy the modern daily changing Dalian with the unforgettable memory in China.
If you have been to prior meetings, we warmly welcome your return as our regular friends. If this is your first meeting, we also welcome you to our “family” gathering.
We look forward to seeing you in Dalian!
Xiaodan Mei, Ph.D.
Executive Chair of
Organizing Committee of CMCB-2016
Ms. Judy Du
Organizing Committee of CMCB-2016
East Wing, 11F, Dalian Ascendas IT Park
No. 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone
LN 116025, P.R.China
Cranial reconstructions will soon be radicalized with the addition of 3D printing and stem cells into the method. A team of scientists from Western Australia will soon attempt this new technique with the intention of seeing the reduction in risk of complications, surgical procedure duration and costs.
The first patients will be those from the Royal Perth Hospital, whose skulls have either been severely damaged or partially removed for brain surgery.
The research team, which includes a surgeon, two engineers, a neurosurgeon and chief scientist will collaborate with a Vienna-based 3D printing firm to replicate the bones from the patients’ cranium.
A printed bioceramic scaffold less than 100 microns (0.1mm) of the original bone will be infused with millions of stem cells. This will be fitted onto the patient’s skull.
This is the first time stem cells will be put to use with 3D printed scaffold to assist in bone regrowth, according to neurosurgeon Marc Coughlan.
“What we’re trying to do is take it one step further and have the ceramic resorb and then be only left with the patient’s bone, which would be exactly the same as having the skull back,” he said.
Health minister Kim Hames says,”This project highlights some of the innovative and groundbreaking research that is under way in WA’s public health system, and the commitment of the government to supporting this crucial work.”
The reconstruction project is part of the nine health and medical projects in Western Australia that has been allocated A$2 Million (US$1.5 Million) research funding grant by the state government. The government’s aim is to eventually reduce costs and improve efficiency in Australia’s public health service through the help of these projects.
Previous methods by past studies had the bone part frozen and stored for later replanting. However, attempts to replant often resulted either in infection or bone resorption. The more popular titanium plates, on the other hand, pose the problem of eventual material degradation.
Source : http://goo.gl/TJTLcT
While a big-data revolution is under way in health care, there is also another silent revolution brewing in healthcare industry in the form of Regenerative Medicine.
In this session of Risk Roundup, Risk Group discusses Regenerative Medicine and Healthcare with GIOSTAR CEO Mr. Deven Patel, CEO, President & Cofounder at Global Institute of Stem Cell Therapy and Research (GIOSTAR) with headquarter in San Diego, California, U.S.A.
GIOSTAR CEO Mr. Deven Patel Visits Saudi Arabia